Related Experiment Videos
[Progressive supranuclear palsy]
1Department of Neurology, Kitasato University School of Medicine.
Rinsho Shinkeigaku = Clinical Neurology
|May 13, 1998
Summary
Progressive supranuclear palsy (PSP) is a neurodegenerative disease distinct from Parkinsonism. Improved diagnostic criteria enhance accuracy for research and treatment.
Area of Science:
- Neuroscience
- Neuropathology
Context:
- Progressive supranuclear palsy (PSP) is a rare neurodegenerative disease.
- Distinguished from Parkinsonism by unique clinical and neuropathological features.
- Diagnostic criteria have evolved to improve accuracy for research and clinical practice.
Purpose:
- To outline the clinical and neuropathological characteristics of PSP.
- To detail diagnostic criteria, including essential symptoms and imaging findings.
- To discuss atypical presentations and their neuropathological correlates.
Summary:
- PSP presents with supranuclear gaze palsy, parkinsonism, gait imbalance, and dementia.
- Essential diagnostic features include supranuclear gaze palsy and bradykinesia.
- Neuropathology reveals neuronal loss, neurofibrillary degeneration, and glial tangles, particularly in the midbrain and basal ganglia.
- MR imaging may show third ventricle dilatation.
Impact:
- Enhanced diagnostic accuracy facilitates targeted therapeutic trials.
- Improved understanding aids in differentiating PSP from other neurological disorders.
- Contributes to etiological investigations and precise clinical phenotyping.